%0 Journal Article
%T Clinic Evaluation of Heart Failure of Old People in the Department of Internal  Medicine of Point G University Hospital from 2008 to 2012
%A Ass¨¦tou Soukho Kaya
%A Abdel Kader Traor¨¦
%A Djibril Sy
%A Djenebou Traor¨¦
%A Ilo Diall
%A Youssouf Fofana
%A Ibahima Amadou Demb¨¦l¨¦
%A Boua Daoud Camara
%A Mamadou Saliou
%A Karim Dao
%A Mamadou Cissoko
%A Kaly K¨¦&iuml
%A ta
%A Barry Boubacar Sangar¨¦
%A Mamadou Mall¨¦
%A Alassane A. Doumbia
%A Hadiza A. Ka&iuml
%A lou
%A Mamadou Demb¨¦l¨¦
%A Hamar Alassane Traor¨¦
%J Open Journal of Internal Medicine
%P 83-88
%@ 2162-5980
%D 2019
%I Scientific Research Publishing
%R 10.4236/ojim.2019.93012
%X <strong>Justification:</strong> Heart failure (HF) is the evolutionary end of all cardiac diseases. Given the aging population, the rate of incidence is increasing among the elderly. <strong>Objectives:</strong> The study aims to determine the prevalence of heart failure in the elderly; to describe the clinical aspects; describe etiologies; describe the therapeutic aspects; and describe the evolution of heart failure among the elderly. <strong>Method:</strong> This was a retrospective study over five years on the operating records of patients hospitalized in the internal medicine department of Hospital Point G. <strong>Result:</strong> The study included records of 22 elderly patients who were with heart failure of a total of 595 patients hospitalized from 1st January 2008 to 31st December 2012. The prevalence rate was 3.7%, and the average age was 67 ¡À 7.79 years. The sex ratio was equal to 1. HTA accounted for the cardiovascular risk factors in 77.3%. 72.7% of patients had the symptom of dyspnea and 95.5% of patients had the symptom of IMO. According to the cardiac ultrasound, dilation of the OG represented 68.2% of cases, followed by impaired LVEF (63.6%). The etiologies of IC were represented by dilated cardiomyopathy (95.5%), followed by 13.6% in cardiothyreosis. Drug treatment was dominated by the use of diuretics, ACE inhibitors and sodium diet respectively 95.5%; 81.8% and 45.5% of cases. The clinical outcome was favorable in 73%. We recorded four (4) cases of death, which accounted for 18% of patients.
%K Heart Failure
%K Clinic
%K Etiology
%K Therapeutics
%K The Elder
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=94853